Author: admin

Continue Reading

  • New combination approach aims to make CAR T more durable in lymphoma

    New combination approach aims to make CAR T more durable in lymphoma

    A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell therapy may sharply boost one-year progression-free survival for people with aggressive lymphoma.

    In just a few years,…

    Continue Reading